Green Biologics raises Series B led by Sofinnova

UK-based Green Biologics has raised a $25 million Series B round led by Sofinnova Partners. Morgan Joseph TriArtisan was exclusive financial advisor to the company.

ByAngela Sormani

4 December 2013•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

North America US Briefs

Green Biologics raises Series B led by Sofinnova

Sofinnova Partners

Capricorn Partners

Cathay Pacific

Oxford Capital

Swire